Characterization of new polymorphisms in the 5′UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level

被引:0
作者
R Bergholdt
ZM Larsen
NA Andersen
J Johannesen
OP Kristiansen
T Mandrup-Poulsen
J Nerup
F Pociot
机构
[1] Steno Diabetes Center,
[2] The Danish Study Group of IDDM in Childhood.,undefined
[3] The Danish IDDM Epidemiology and Genetics Group. The study was supported by grants from the Danish Medical Research Council (No. 9802011),undefined
[4] EEC (BMH-CT97-2311 and BMH4-CT98-3363 (DG12-SSMI)),undefined
[5] The Poul and Erna Sehested-Hansen Foundation and Novo Nordisk A/S. OPK is a recipient of a JDFI fellowship grant (JDFI number 3-1999-21).,undefined
来源
Genes & Immunity | 2000年 / 1卷
关键词
interleukin-1 receptor; polymorphisms; functional genetics; diabetes; PEP-DNA;
D O I
暂无
中图分类号
学科分类号
摘要
The human interleukin-1 type I receptor (IL-1RI) is the signal transducing receptor for IL-1, a principal proinflammatory cytokine, which is cytotoxic to pancreatic islet beta cells. The IL-1RI gene, IL1R1, maps to chromosome 2q12. We have previously examined part of the IL1R1 promoter region and in the present study we further characterized the promoter region demarcating exon 1B and 1C by sequencing and mutation scanning. New sequence was obtained 1762 bp upstream and 1609 bp downstream the known region. Within this sequence, we identified four frequent single nucleotide polymorphisms (SNPs). PCR-based RFLP assays were established and three of the polymorphisms were typed in a Danish Type 1 (insulin-dependent) diabetes mellitus (T1DM) family collection comprising 103 simplex and 150 sib-pair affected families. Linkage was evaluated by the sib-TDT (transmission disequilibrium test). One of the polymorphisms, defined by a HinfI RFLP assay, demonstrated linkage to T1DM, P(sTDT) = 0.026. Random transmission was observed to unaffected offspring from heterozygous parents, P = 0.87. No evidence for positive linkage was seen for the other tested polymorphisms, P = 0.14 and P = 0.21, respectively. To evaluate the possible functional significance of the HinfI polymorphism, we measured circulating IL-1RI plasma level in 30 T1DM patients and in 30 control subjects – 10 with each genotype in both groups. Significant differences in plasma levels in relation to genotype – independent of disease status – were found (P = 0.04). In both diabetic and non-diabetic subjects, the wt/wt genotype correlated with the highest IL-1RI plasma level, whereas the plasma levels were lowest for the mt/mt genotype.
引用
收藏
页码:495 / 500
页数:5
相关论文
共 50 条
  • [21] The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese
    Asano, Katsuaki
    Ikegami, Hiroshi
    Fujisawa, Tomomi
    Kawabata, Yumiko
    Noso, Shinsuke
    Hiromine, Yoshihisa
    Ogihara, Toshio
    IMMUNOLOGY OF DIABETES IV: PROGRESS IN OUR UNDERSTANDING, 2006, 1079 : 47 - 50
  • [22] Melatonin receptor 1A (MTNR1A) gene linkage and association to type 2 diabetes in Italian families
    Amin, M.
    Gragnoli, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (10) : 4688 - 4692
  • [23] Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
    Larsen, Claus M.
    Faulenbach, Mirjam
    Vaag, Allan
    Ehses, Jan A.
    Donath, Marc Y.
    Mandrup-Poulsen, Thomas
    DIABETES CARE, 2009, 32 (09) : 1663 - 1668
  • [24] The analysis of interleukin-1 receptor antagonist and interleukin-1β gene polymorphisms in Turkish FMF patients: do they predispose to secondary amyloidosis?
    Balci-Peynircioglu, B.
    Taskiran, Z. E.
    Tuerel, B.
    Arici, M.
    Bakkaloglu, A.
    Oezen, S.
    Yilmaz, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : S99 - S102
  • [25] Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1α protein in gingival crevicular fluid of teeth with severe periodontal disease
    Shirodaria, S
    Smith, J
    McKay, IJ
    Kennett, CN
    Hughes, FJ
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (11) : 1864 - 1869
  • [26] Association of BANK1 and cytokine gene polymorphisms with type 1 diabetes in Tunisia
    Zouidi, Ferjani
    Stayoussef, Mouna
    Bouzid, Dorra
    Fourati, Hajer
    Abida, Olfa
    Joao, Costa
    Ben Ayed, Mourad
    Fakhfakh, Raouia
    Thouraya, Kammoun
    Monjia, Hachicha
    Carlos, Penha-Goncalves
    Masmoudi, Hatem
    GENE, 2014, 536 (02) : 296 - 301
  • [27] Functional polymorphisms of DEFB1 gene in type 1 diabetes Brazilian children
    Guimaraes, R. L.
    Segat, L.
    Rocha, C. R. C.
    Brandao, L. A. C.
    Zanin, V.
    Araujo, J.
    Naslavsky, M. S.
    De Lima Filho, J. L.
    Crovella, S.
    AUTOIMMUNITY, 2009, 42 (05) : 406 - 413
  • [28] Interleukin-1 beta targeted therapy for type 2 diabetes
    Maedler, Kathrin
    Dharmadhikari, Gitanjali
    Schumann, Desiree M.
    Storling, Joachim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (09) : 1177 - 1188
  • [29] Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Lee, Kee-Hyoung
    PEDIATRIC DIABETES, 2019, 20 (06) : 750 - 758
  • [30] Genetic association of interleukin-1β (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians
    Achyut, B. R.
    Srivastava, Akanksha
    Bhattacharya, Sandeep
    Mittal, Balraj
    CLINICA CHIMICA ACTA, 2007, 377 (1-2) : 163 - 169